(Q73668731)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761749%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761749%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

metastatic colon cancer

1 reference

1 reference

1 reference

1 reference

C Levy-Piedbois

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761749%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

I Durand-Zaleski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761749%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Juhel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761749%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

C Schmitt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761749%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Bellanger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761749%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P Piedbois

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761749%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761749%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761749%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761749%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761749%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

157-161

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761749%20AND%20SRC:MED&resulttype=core&format=json

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008358411251

7 January 2021

Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008358411251

7 January 2021

Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008358411251

7 January 2021

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008358411251

7 January 2021

Irinotecan for colorectal cancer: a small step forward

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008358411251

7 January 2021

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008358411251

7 January 2021

Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma. A multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008358411251

7 January 2021

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008358411251

7 January 2021

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008358411251

7 January 2021

Efficacy and cost-effectiveness of cancer treatment: rational allocation of resources based on decision analysis.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008358411251

7 January 2021

Identifiers

DOI

10.1023/A:1008358411251

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761749%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference